PDF-and Research (CDER)

Author : test | Published Date : 2016-10-30

CMC 3 OF CONTENTS 1 II TYPES OF CHROMATOGRAPHY High Performance Liquid Chromatography HPLC

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "and Research (CDER)" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

and Research (CDER): Transcript

CMC 3 OF CONTENTS 1 II TYPES OF CHROMATOGRAPHY High Performance Liquid Chromatography HPLC . 6 POLICY AND PROCEDURES OFFICE OF NEW DRUGS Good Review Practice Management of Breakthrough TherapyDesignated Drugs and Biologics Table of Contents PURPOSE 1 BACKGROUND Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 51, rm Additional copies are available from: Office of Communications Division of Drug Information, WO51, Room 2201 10903 New Hampshire Ave. Silver Spring, MD 20993 Phone: 301-796-3400; Fax: 301-847-8714 dr Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10001 New Hampshire Ave., Hillandale B INDICATED FOR THE REDUCTION OF EXCESS ABDOMINAL FA T IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY NDA 201532ERIBULIN MESYLATEERIBULIN MESYLATEEISAI INCP11/15/2010 INDICATED FOR FOR THE TREATMENT OF PAT ilable from: Dsion of Drug Information 101 New Hampshire Ave. 0993 1-847-8714 ov yInformation/Guidances/default.htmAdditional copies are avaOffice of Communications iviSilver Spring, MD 2Phone: 301- Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 51, rm Melanie Hartsough, Ph.D.. Biologics Consulting Group, . Inc. 1. CDER: approximately 3,600 FTEs in 2013. 18 review divisions-divided based on . indication. CDER: average of 26 NMEs approved per year. Due to volume of work try to standardize requirements. Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10903 New Hampshire Ave., Bldg. 51, rm Additional copies are available from: Office of Communications Division of Drug Information, WO51, Room 2201 Center for Drug Evaluation and ResearchFood and Drug Administration 10903 New Hampshire Av Varda. . Bondy. and Carolyn . Hirst. (Thursday). Margaret Doyle and Nick O’Brien (Friday). What is ‘research’?. re·search. : NOUN: 1. a detailed study of a subject, especially in order to discover (new) information or reach a (new) understanding.. Joint Financial Management Improvement Program (JFMIP) DATA Act Section 5 Grants Pilot May 9, 2016 2 Presenters Karen Lee Nicole Martinez Moore Office of Management and Budget (OMB) Christopher Zeleznik Additional copies are available from Office of Communications Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10001 New Hampshire Ave Hillandale Bldg Additional copies are available from: Office of Communications, Division of Drug Information Center for Drug Evaluation and Research Food and Drug Administration 10001 New Hampshire Ave., Hillandale B

Download Document

Here is the link to download the presentation.
"and Research (CDER)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.